BeiGene, Ltd.
Fused tricyclic compounds as Raf kinase inhibitors
Last updated:
Abstract:
Provided are certain fused tricyclic compounds and salts thereof, compositions thereof, and methods of use therefor.
Status:
Grant
Type:
Utility
Filling date:
29 Jan 2018
Issue date:
3 Mar 2020